Neuralia TMS: Pioneering Transcranial Magnetic Stimulation Therapy for Mental Health and Chronic Pain in Perth

November 15, 2023 09:11 PM AEDT | By EIN Presswire
 Neuralia TMS: Pioneering Transcranial Magnetic Stimulation Therapy for Mental Health and Chronic Pain in Perth
Image source: EIN Presswire
PERTH, WESTERN AUSTRALIA, AUSTRALIA, November 15, 2023 /EINPresswire.com/ -- Neuralia TMS, a leading provider of Transcranial Magnetic Stimulation (TMS) therapy, is making waves in the field of mental health and chronic pain treatment. Specialising in non-pharmacological interventions, Neuralia TMS is dedicated to improving the lives of individuals suffering from conditions such as Depression, PTSD, OCD, Chronic Pain (including Fibromyalgia), and more.

Revolutionising Mental Health and Chronic Pain Treatment

Neuralia TMS is at the forefront of a revolution in mental health care and chronic pain management. With a commitment to excellence and innovation, the clinic is changing the lives of countless individuals in the Perth area.

Access to Quality Care

One of the standout features of Neuralia TMS is its commitment to making TMS therapy accessible to all who need it. The clinic is proud to offer TMS treatments that are fully covered by Medicare. This crucial development ensures that a wider range of individuals can access this effective treatment, reducing the financial burden on patients and making it available to more people in need.

A Holistic, Drug-Free Approach

Neuralia TMS stands out by prioritising non-pharmacological interventions, offering a drug-free alternative to traditional treatment methods. This approach is particularly beneficial for those who are seeking holistic, non-invasive solutions to their mental health and chronic pain challenges.

Backed by Decades of Research

One of the cornerstones of Neuralia TMS's success is its unwavering commitment to evidence-based practice. TMS therapy has a rich history of research spanning over 35 years, ensuring the effectiveness and reliability of this innovative treatment. Patients can trust that the therapy they receive is grounded in extensive research and scientific rigour.

Precision in Healing

TMS therapy represents a groundbreaking treatment modality that precisely targets specific brain regions, resulting in long-lasting therapeutic outcomes. By stimulating neural activity in underactive brain areas associated with mental illnesses and chronic pain, TMS promotes lasting changes in brain circuitry, leading to improved patient outcomes.

Life-Changing Advantages for Patients:

Choosing TMS therapy at Neuralia TMS comes with numerous advantages for patients, including:

Convenience: TMS treatments are designed to seamlessly integrate into patients' daily routines without requiring recovery time or hospital admissions. This makes TMS a practical choice for individuals with busy lives who may not have time for extended treatments or recovery periods.

Minimal Disruption: TMS therapy does not induce withdrawal symptoms or downtime. This enables individuals to continue with their regular activities, maintaining their commitments and responsibilities while receiving essential therapy.

Lasting Effects: The effects of TMS therapy are typically enduring, providing patients with sustained relief from their symptoms. Neuralia TMS is dedicated to delivering long-term benefits for patients, empowering them to take control of their mental health and pain management.

A Message from the Managing Director

"At Neuralia TMS, we are committed to delivering professional, evidence-based, and patient-centered care," said Riti Chetty, Managing Director at Neuralia TMS. "Our dedicated team of experts is eager to provide you with transformative TMS therapy, offering a beacon of hope to those seeking effective and lasting relief from mental health conditions and chronic pain."

Learn More About Neuralia TMS
For more information about Neuralia TMS and the services they offer, please visit their website at https://www.neuraliatms.com.au/.

About Neuralia TMS:
Industry: Mental Health Care
Company size: 2-10 employees
Headquarters: Palmyra, Western Australia
Type: Privately Held
Founded: 2021
Specialities: Depression, PTSD, Chronic Pain, Anxiety Disorder, Bipolar Disorder, Addiction, Cognitive Enhancement, Insomnia, and Neurological Disorders

Visit Neuralia TMS at Multiple Locations:

Palmyra: 7/25 Foss St, Palmyra, Western Australia 6157, Australia
West Leederville: 2/160a Cambridge Street, West Leederville, Western Australia 6007, Australia
Nedlands: Ramsay Clinic Hollywood, 95 Monash Ave, Nedlands WA 6009, Australia
Midland: 2 Tuckeroo Parade, Helena Valley WA 6056, Australia
Bunbury: 15/135 Victoria Street, Bunbury, Western Australia 6230, Australia
Busselton: 190 Bussell Hwy, Busselton WA 6280, Australia
Albany: 2 Pioneer Road, Albany, Western Australia 6330, AU

Media Contact:
Dr. Shanek Wick, Interventional 𝗣𝘀𝘆𝗰𝗵𝗶𝗮𝘁𝗿𝗶𝘀𝘁 & 𝗗𝗶𝗿𝗲𝗰𝘁𝗼𝗿 @ Neuralia TMS
Dr. Riti Chetty, Managing Director at Neuralia TMS
For more information, please contact Neuralia TMS at [email protected] - 08 6230 3996.

Dr Shanek Wick
Neuralia TMS
+61 8 6230 3996
[email protected]
Visit us on social media:
Facebook
LinkedIn
Instagram


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.